Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 1
2005 1
2007 1
2008 1
2009 1
2013 1
2014 1
2016 2
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions.
Moscucci M, Share D, Kline-Rogers E, O'Donnell M, Maxwell-Eward A, Meengs WL, Clark VL, Kraft P, De Franco AC, Chambers JL, Patel K, McGinnity JG, Eagle KA; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Moscucci M, et al. J Interv Cardiol. 2002 Oct;15(5):381-6. doi: 10.1111/j.1540-8183.2002.tb01071.x. J Interv Cardiol. 2002. PMID: 12440181 Free article.
Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC).
Ambulgekar NV, Grey SF, Rosman HS, Othman H, Davis TP, Nypaver TJ, Schreiber T, Yamasaki H, Lalonde TA, Henke PK, Gurm HS, Mehta RH, Grossman PM; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Investigators. Ambulgekar NV, et al. J Invasive Cardiol. 2018 Jan;30(1):35-42. J Invasive Cardiol. 2018. PMID: 29289948 Free article.
Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Aboufakher R, Riba A, Jani SM, Goswami R, Schwartz S, Lins S, Gardin J, Smith DE, Kline-Rogers E, Share D, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Aboufakher R, et al. Am Heart J. 2005 Sep;150(3):455-8. doi: 10.1016/j.ahj.2004.12.011. Am Heart J. 2005. PMID: 16169323
Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience.
Kline-Rogers E, Share D, Bondie D, Rogers B, Karavite D, Kanten S, Wren P, Bodurka C, Fisk C, McGinnity J, Wright S, Fox S, Eagle KA, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Kline-Rogers E, et al. J Interv Cardiol. 2002 Oct;15(5):387-92. doi: 10.1111/j.1540-8183.2002.tb01072.x. J Interv Cardiol. 2002. PMID: 12440182 Free article.
Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, Lalonde T, Kline-Rogers E, O'Donnell M, O'Neill W, Safian R, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Gurm HS, et al. J Interv Cardiol. 2007 Jun;20(3):197-203. doi: 10.1111/j.1540-8183.2007.00262.x. J Interv Cardiol. 2007. PMID: 17524111 Free article. Clinical Trial.
Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2]).
Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, Chetcuti S, Grossman PM, Nallamothu B, O'Donnell M, DeFranco A, Maxwell-Eward A, McGinnity J, Meengs WM, Patel K, Moscucci M; Blue Cross & Blue Shield of Michigan Cardiovascular Consortium (BMC2). Mukherjee D, et al. Am J Cardiol. 2003 Oct 15;92(8):972-4. doi: 10.1016/s0002-9149(03)00981-0. Am J Cardiol. 2003. PMID: 14556876
Preprocedural statin use in patients undergoing percutaneous coronary intervention.
Kenaan M, Seth M, Aronow HD, Naoum J, Wunderly D, Mitchiner J, Moscucci M, Gurm HS; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Kenaan M, et al. Am Heart J. 2014 Jul;168(1):110-6.e3. doi: 10.1016/j.ahj.2014.03.016. Epub 2014 Apr 5. Am Heart J. 2014. PMID: 24952867 Clinical Trial.
Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
Khambatta S, Othman H, Seth M, Lalonde T, Rosman HS, Gurm HS, Mehta RH; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Investigators. Khambatta S, et al. Cardiovasc Revasc Med. 2016 Jun;17(4):233-40. doi: 10.1016/j.carrev.2016.02.014. Epub 2016 Feb 27. Cardiovasc Revasc Med. 2016. PMID: 26994504
14 results